NCT03678883: 9-ING-41 in Patients With Advanced Cancers
- State
- Under way
- Phase
- Phase 2
- People
- 350 planned
- Started
- 4 Jan 2019
- Primary completion
- Jun 2026
- Arms
- 9-ING-41 plus Paclitaxel/Carboplatin
- Results
- None posted
- 20 Sep 2018: Trial registered
- 4 Jan 2019: Trial started